Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Beta Bionics (BBNX) Enterprise Value (2023 - 2025)

Beta Bionics' Enterprise Value history spans 3 years, with the latest figure at -$31.7 million for Q4 2025.

  • For Q4 2025, Enterprise Value rose 69.42% year-over-year to -$31.7 million; the TTM value through Dec 2025 reached -$31.7 million, up 69.42%, while the annual FY2025 figure was -$31.7 million, 69.42% up from the prior year.
  • Enterprise Value for Q4 2025 was -$31.7 million at Beta Bionics, up from -$228.7 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$13.0 million in Q2 2024 and bottomed at -$249.7 million in Q2 2025.
  • The 3-year median for Enterprise Value is -$96.7 million (2023), against an average of -$110.5 million.
  • The largest YoY upside for Enterprise Value was 69.42% in 2025 against a maximum downside of 1816.65% in 2025.
  • A 3-year view of Enterprise Value shows it stood at -$96.7 million in 2023, then decreased by 7.06% to -$103.6 million in 2024, then skyrocketed by 69.42% to -$31.7 million in 2025.
  • Per Business Quant, the three most recent readings for BBNX's Enterprise Value are -$31.7 million (Q4 2025), -$228.7 million (Q3 2025), and -$249.7 million (Q2 2025).